6533b822fe1ef96bd127d588

RESEARCH PRODUCT

LP24 : Safety, efficacy and impact on liver function of simeprevir (SMV) in combination with daclatasvir (DCV) or sofosbuvir (SOF) in patients with severe hepatitis C recurrence after liver transplantation (LT): results from compassionate use in europe

C. MorenoU. Visco ComadiniR. Lionetti LionettiCarlo TortiMarco BiolatoMartina SterneckVincenza CalvarusoOla WeilandK. HeznerPaola CarraiAhmed M. El-sharkawyMaría-carlota LondoñoXavier Forns

subject

Simeprevirmedicine.medical_specialtyDaclatasvirHepatologySofosbuvirbusiness.industrymedicine.medical_treatmentCompassionate UseLiver transplantationGastroenterologyHepatitis a virusSurgeryInternal medicinemedicineIn patientLiver functionbusinessmedicine.drughttps://doi.org/10.1016/s0168-8278(15)30178-1